David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.04% |
| 2 | Healthcare | 13.44% |
| 3 | Consumer Discretionary | 13.38% |
| 4 | Financials | 7.19% |
| 5 | Industrials | 6.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1626
HNI Corp
HNI
$3.6B
| $4.13M | 0.01% |
113,753
+17,362
| +18% | +$668K |
|
1627
American Tower
AMT
$81.9B
| $4.11M | 0.01% |
20,872
+11,989
| +135% | +$2.1M |
|
1628
Zillow
ZG
$8.09B
| $4.11M | 0.01% |
120,017
+5,769
| +5% | +$204K |
|
1629
Edgewell Personal Care
EPC
$1.32B
| $4.09M | 0.01% |
+93,287
| New | +$3.89M |
|
|
WAIR
1630
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $4.09M | 0.01% |
465,662
+214,160
| +85% | +$1.76M |
|
1631
Graham Holdings Company
GHC
$4.93B
| $4.08M | 0.01% |
5,980
-246
| -4% | -$165K |
|
1632
CALL
ArcelorMittal
MT
$56.2B
| $4.08M | 0.01% |
200,400
+181,400
| +955% | +$4.02M |
|
1633
CytomX Therapeutics
CTMX
$723M
| $4.08M | 0.01% |
379,754
+246,072
| +184% | +$3.64M |
|
1634
PUT
Avis
CAR
$5.09B
| $4.07M | 0.01% |
116,700
+24,900
| +27% | +$746K |
|
1635
FS KKR Capital
FSK
$3.36B
| $4.07M | 0.01% |
168,052
+85,889
| +105% | +$2.13M |
|
1636
Onto Innovation
ONTO
$17.8B
| $4.05M | 0.01% |
131,146
+76,617
| +141% | +$2.25M |
|
1637
Tyler Technologies
TYL
$14.4B
| $4.05M | 0.01% |
19,800
+4,175
| +27% | +$827K |
|
|
NXGN
1638
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $4.04M | 0.01% |
240,300
-14,499
| -6% | -$251K |
|
|
CRAY
1639
DELISTED
Cray, Inc.
CRAY
| $4.04M | 0.01% |
155,090
-65,322
| -30% | -$1.52M |
|
|
BFX
1640
DELISTED
BowFlex Inc.
BFX
| $4.04M | 0.01% |
726,298
+411,396
| +131% | +$3.18M |
|
|
SGI
1641
PUT
Somnigroup International
SGI
$13.2B
| $4.04M | 0.01% |
280,000
-120,000
| -30% | -$1.62M |
|
1642
Boot Barn
BOOT
$4.84B
| $4.03M | 0.01% |
+136,826
| New | +$3.45M |
|
1643
Coeur Mining
CDE
$22B
| $4.02M | 0.01% |
984,367
-1,581,149
| -62% | -$7.63M |
|
1644
Sinclair Inc
SBGI
$1.04B
| $4.01M | 0.01% |
104,169
-54,272
| -34% | -$1.82M |
|
1645
CALL
Norfolk Southern
NSC
$79.2B
| $4M | 0.01% |
21,400
-94,900
| -82% | -$16.4M |
|
|
B
1646
CALL
Barrick Mining
B
$77.4B
| $4M | 0.01% |
291,400
-36,500
| -11% | -$472K |
|
|
EV
1647
DELISTED
Eaton Vance Corp.
EV
| $3.99M | 0.01% |
99,068
-189,452
| -66% | -$7.52M |
|
1648
Materion
MTRN
$4.92B
| $3.99M | 0.01% |
69,971
+28,055
| +67% | +$1.46M |
|
1649
PUT
Newell Brands
NWL
$2.54B
| $3.99M | 0.01% |
260,200
+55,200
| +27% | +$1.01M |
|
1650
PUT
Ovintiv
OVV
$17.8B
| $3.99M | 0.01% |
110,244
+52,244
| +90% | +$1.79M |
|
Similar funds
David Shaw's Q1 2019 Portfolio in Review
As of Q1 2019, David Shaw held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
David Shaw withdrew a net $6.74B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, David Shaw opened a new position in Lyft worth $159M.
- David Shaw's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- David Shaw added most to Pfizer in Q1 2019, an estimated $436M increase.
- David Shaw's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- David Shaw fully exited Shire pic in Q1 2019, selling an estimated $276M.
- David Shaw's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- David Shaw opened 447 new positions and closed 617 in Q1 2019.
- David Shaw's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.